<i>In Vitro</i> Comparison of Aztreonam/Amoxicillin-Clavulanate Versus Aztreonam/Ceftazidime-Avibactam on Ceftazidime-Avibactam Resistant <i>Stenotrophomonas maltophilia</i>-Reference-Cited by-同舟云学术

In Vitro Comparison of Aztreonam/Amoxicillin-Clavulanate Versus Aztreonam/Ceftazidime-Avibactam on Ceftazidime-Avibactam Resistant Stenotrophomonas maltophilia

Published:2022-08-01 Issue:8 Volume:28 Page:877-881
ISSN:1076-6294
Container-title:Microbial Drug Resistance
language:en
Short-container-title:Microbial Drug Resistance

Author:

Crémet Lise¹²^ORCID,Joffraud Léo¹,Eschapasse Emmanuel³,Bihouée Tiphaine⁴,Tissot Adrien³,Gibaud Sophie¹,Persyn Elise¹

Affiliation:

1. Service de Bactériologie-Hygiène, Pôle de Biologie, CHU Nantes, Nantes, France.

2. CHU Nantes, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, Nantes Université, Nantes, France.

3. Service de Pneumologie, Hôpital Nord Laennec, CHU Nantes, Nantes, France.

4. CRCM pédiatrique, Hôpital Mère-enfant, CHU Nantes, Nantes, France.

Publisher

Mary Ann Liebert Inc

Subject

Microbiology (medical),Pharmacology,Immunology,Microbiology

Link

https://www.liebertpub.com/doi/pdf/10.1089/mdr.2021.0389

Reference22 articles.

1. Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options

2. Achromobacter xylosoxidans and Stenotrophomonas maltophilia: Emerging Pathogens Well-Armed for Life in the Cystic Fibrosis Patients’ Lung

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolving resistance landscape in gram‐negative pathogens: An update on β‐lactam and β‐lactam‐inhibitor treatment combinations for carbapenem‐resistant organisms;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2024-07

2. Treatment approaches for severe Stenotrophomonas maltophilia infections;Current Opinion in Infectious Diseases;2023-10-16

3. Rationale and evidence for the use of new beta-lactam/beta-lactamase inhibitor combinations and cefiderocol in critically ill patients;Annals of Intensive Care;2023-07-18